ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $163,507 (100.0% shares, 0.0% debt)

Holdings (7)

RVMD REVOLUTION MEDICINES, INC. 56.7%

Value ($000) $92,736 Shares 3,233,490 Est. Cost $24.03 Unrealized 0.0%

— VERVE THERAPEUTICS, INC. 17.1%

Value ($000) $28,003 Shares 2,008,809 Est. Cost $36.87 Unrealized —

ERAS ERASCA, INC. 14.4%

Value ($000) $23,548 Shares 11,055,554 Est. Cost $17.12 Unrealized -87.7%

DNLI DENALI THERAPEUTICS, INC. 5.0%

Value ($000) $8,182 Shares 381,249 Est. Cost $26.20 Unrealized -24.4%

GOSS GOSSAMER BIO, INC. 4.5%

Value ($000) $7,351 Shares 8,055,916 Est. Cost $1.15 Unrealized -35.9%

— UNITY BIOTECHNOLOGY, INC. 1.2%

Value ($000) $1,939 Shares 1,004,817 Est. Cost $0.40 Unrealized —

— SINGULAR GENOMICS SYSTEMS, INC. 1.1%

Value ($000) $1,748 Shares 3,798,926 Est. Cost $11.56 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RVMD	REVOLUTION MEDICINES, INC.	3,233,490	$92,736	56.7%	$24.03	0.0%	COM	76155X100
—	VERVE THERAPEUTICS, INC.	2,008,809	$28,003	17.1%	$36.87	—	COM	92539P101
ERAS	ERASCA, INC.	11,055,554	$23,548	14.4%	$17.12	-87.7%	COM	29479A108
DNLI	DENALI THERAPEUTICS, INC.	381,249	$8,182	5.0%	$26.20	-24.4%	COM	24823R105
GOSS	GOSSAMER BIO, INC.	8,055,916	$7,351	4.5%	$1.15	-35.9%	COM	38341P102
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$1,939	1.2%	$0.40	—	COM	91381U200
—	SINGULAR GENOMICS SYSTEMS, INC.	3,798,926	$1,748	1.1%	$11.56	—	COM	82933R100